Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Depreciation & Amortization (CF) (2023 - 2025)

Cardio Diagnostics Holdings' Depreciation & Amortization (CF) history spans 3 years, with the latest figure at $5655.0 for Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) rose 17.76% year-over-year to $5655.0; the TTM value through Sep 2025 reached $118532.0, up 660.02%, while the annual FY2024 figure was $113777.0, 2902.03% up from the prior year.
  • Depreciation & Amortization (CF) for Q3 2025 was $5655.0 at Cardio Diagnostics Holdings, down from $37785.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $37785.0 in Q2 2025 and bottomed at $1377.0 in Q3 2023.
  • The 3-year median for Depreciation & Amortization (CF) is $4802.0 (2024), against an average of $15056.1.
  • The largest annual shift saw Depreciation & Amortization (CF) skyrocketed 1451.43% in 2024 before it increased 17.76% in 2025.
  • A 3-year view of Depreciation & Amortization (CF) shows it stood at $2413.0 in 2023, then surged by 1451.43% to $37436.0 in 2024, then plummeted by 84.89% to $5655.0 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Depreciation & Amortization (CF) are $5655.0 (Q3 2025), $37785.0 (Q2 2025), and $37656.0 (Q1 2025).